A new platform for customized medicine via 3D printing

CurifyLabs and Natural Machines have entered a strategic partnership to develop a technology that enables customized medicine production through 3D printing – producing personalized medicines for human and veterinary patients, on-site in pharmacies and hospitals. Compounding is the manual preparation of individualized drug treatments for patients where an optimal treatment cannot be achieved with the currently available medicinal products. There are many talented pharmacists who are able to compound drugs manually but the process is ineffective and lacks quality control.

“With this partnership, we are developing a unique Medicine-as-a-Service concept for pharmacy compounding and we believe that our partnership with Natural Machines will bring an affordable and superior 3D printing platform to the market. Together we can revolutionize the industry within personalized medicine offering localized, on-demand drug manufacturing.”, said Charlotta Topelius, CEO, CurifyLabs.

This partnership aims to develop a unique solution that optimizes and automates the compounding process in pharmacies and hospitals, by utilizing 3D printers. CurifyLabs will commercialize the solution on a global scale. The two companies aim to introduce the technology to the market globally during 2022.

“Our initial pilots have proved the potential to print personalized medicines based on CurifyLabs’ pharmaceutical formulations. We continue to focus on adapting the technology to establish a new approach for personalized medicine for our customers, based on pharma grade ingredients and integrated quality control”, said Niklas Sandler Topelius, Chief Scientific Officer, CurifyLabs.

“Our partnership with CurifyLabs will help us to grow our portfolio. At Natural Machines, we have solutions for the food sector and the personal care industry, and now with this strategic partnership, we add the pharmaceutical field. This partnership will leverage both CurifyLabs’ experience and latest developments in pharma with our extensive 3D printing expertise, providing a new solution that aligns with the growing global trend of product personalization,” said Lynette Kucsma, founder and CMO of Natural Machines.